Eye surface tumor imaging study
Part of Cancer, Eyes & vision clinical trials.
This study uses a special camera (OCT) to take detailed pictures of growths on the eye's surface. It aims to help doctors tell if a growth is cancerous without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a growth on the surface of your eye
- Your doctor suspects the growth might be a tumor (neoplasm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin growths near the eye using a special camera. It may help doctors better understand and diagnose these growths without needing a biopsy.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
This study compares two non-invasive imaging machines (OCT) that take detailed pictures of eye tumors. The goal is to see which machine gives better images, helping doctors choose the best tool for diagnosing and monitoring eye tumors.
This study tests whether patients can use a portable eye-imaging device (OCT, which takes detailed pictures of the eye) at home to monitor their own eye health. The goal is to see if self-monitoring helps patients track changes and work better with their eye doctors.
This study uses an imaging scan called optical coherence tomography (a non-painful light scan) during surgery to map what “normal” eye tissue looks like. It may help improve how eye specialists assess eyes in the future.
This observational study looks at eyes with iris tumors and compares them to eyes without iris problems. The goal is to better understand how iris circulation and related eye measurements differ, which may help future care.
Hear when a new Ocular Surface Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.